pyrroles has been researched along with icatibant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breipohl, G; Kettenbach, B; Linz, W; Martorana, PA; Schölkens, BA | 1 |
| Ahmed, S; Aziz, Q; Blackshaw, LA; Boundouki, G; Broad, J; Bulmer, DC; Chan, C; Cibert-Goton, V; Hockley, JRF; Knowles, CH; Kung, V; McGuire, C; Peiris, M; Reed, D; Sanger, GJ; Thaha, MA | 1 |
2 other study(ies) available for pyrroles and icatibant
| Article | Year |
|---|---|
Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Dogs; Hydrogen-Ion Concentration; Myocardial Infarction; Oligopeptides; Pyrroles; Ramipril | 1990 |
Ex vivo study of human visceral nociceptors.
Topics: Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Drug Evaluation, Preclinical; Gastrointestinal Agents; Humans; Indoles; Intestines; Morpholines; Nociceptors; Physical Stimulation; Pyrroles; Serotonin Receptor Agonists; Tissue Culture Techniques; TRPV Cation Channels | 2018 |